Rivaroxaban (Xarelto) Picks Up New VTE Indication in Acutely Ill
The new indication provides an oral-only option for acutely ill medical patients, and is the eighth to date granted by the FDA to the direct oral anticoagulant.
Related Articles
Severe Hypertriglyceridemia Education Hub
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
Pulmonary Arterial Hypertension Fellows Forum: Key Insights on Diagnosis and Referral Practices
Pulmonary arterial hypertension (PAH) is a progressive, life-threatening condition that imposes significant physical, emotional, and financial burdens on pat…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
TG Takeover: Rapid-Fire Updates on Advances in sHTG and FCS
Join us for this live event.Hypertriglyceridemia is a causal contributor to atherosclerotic cardiovascular disease (ASCVD), and when triglyceride (TG) levels…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Severe Hypertriglyceridemia Education Hub
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
Severe Hypertriglyceridemia Education Hub
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…